<DOC>
	<DOCNO>NCT00764556</DOCNO>
	<brief_summary>Patients chronic obstructive pulmonary disease ( COPD ) commonly admit hospital exacerbation lung disease . A combination acute illness treatment oral steroid cause rise blood sugar . Patients high blood sugar bad normal blood sugar . The aim study develop safe effective protocol tight control blood glucose insulin acute medical ward outside intensive care environment . This allow u perform formal trial determine whether blood glucose control insulin reduces death complication COPD exacerbation .</brief_summary>
	<brief_title>Phase II Study Safety Feasibility Intensive Blood Glucose Control With Insulin Acute Medical Wards</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Physician diagnosis AECOPD primary cause admission Able enter study within 24 hour admission Intensive care unit admission Moribund active treatment Admission expect last &lt; 48 hour Unable unwilling give inform consent Known Type I diabetes mellitus Patients reduce awareness hypoglycaemia include reduce Glasgow coma scale take beta blocker Patients renal hepatic failure increase risk hypoglycaemia</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Glucose</keyword>
	<keyword>Insulin</keyword>
	<keyword>COPD</keyword>
	<keyword>Exacerbations</keyword>
	<keyword>Tight glycaemic control</keyword>
	<keyword>Acute hospital ward</keyword>
</DOC>